Literature DB >> 7771916

Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity.

J Biederman1, S Milberger, S V Faraone, K Kiely, J Guite, E Mick, S Ablon, R Warburton, E Reed.   

Abstract

BACKGROUND: This study investigated whether family-environment risk factors are associated with attention-deficit hyperactivity disorder (ADHD). Compelling work by Rutter and coworkers revealed that it was the aggregate of adversity factors (severe marital discord, low social class, large family size, paternal criminality, maternal mental disorder, and foster care placement) rather than the presence of any single factor that led to impaired development. Based on the work of Rutter, we hypothesized a positive association between indicators of adversity and the diagnosis of ADHD and ADHD-associated impairments.
METHODS: We studied 140 ADHD and 120 normal control probands. Subjects were non-Hispanic white boys between the ages of 6 and 17 years. Rutter's indicators of adversity were used to predict ADHD-related psychopathology as well as impaired cognitive and psychosocial functioning.
RESULTS: The odds ratio for the diagnosis of ADHD increased as the number of Rutter's adversity index predicted ADHD-related psychopathology (depression, anxiety, and conduct disorder), learning disabilities, cognitive impairment, and psychosocial dysfunction.
CONCLUSIONS: A positive association appears to exist between adversity indicators and the risk for ADHD as well as for its associated psychiatric, cognitive, and psychosocial impairments. These findings support the work of Rutter and stress the importance of adverse family-environment variables as risk factors for children with ADHD.

Entities:  

Mesh:

Year:  1995        PMID: 7771916     DOI: 10.1001/archpsyc.1995.03950180050007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  83 in total

Review 1.  Non-stimulant treatments for ADHD.

Authors:  J Biederman; T Spencer
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

3.  Co-existing symptoms and risk factors among African school children with hyperactivity-inattention symptoms in Kinshasa, Congo.

Authors:  Espérance Kashala; Astri Lundervold; Kristian Sommerfelt; Thorkild Tylleskär; Irene Elgen
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-31       Impact factor: 4.785

4.  Child and Informant Influences on Behavioral Ratings of Preschool Children.

Authors:  Beth M Phillips; Christopher J Lonigan
Journal:  Psychol Sch       Date:  2010-04

5.  Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.

Authors:  Aynur Pekcanlar Akay; Halil Resmi; Sevay Alsen Güney; Handan Özek Erkuran; Gonca Özyurt; Enis Sargin; Ahmet Topuzoglu; Ali Evren Tufan
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-14       Impact factor: 4.785

6.  Differential family and peer environmental factors are related to severity and comorbidity in children with ADHD.

Authors:  C J M Buschgens; M A G van Aken; S H N Swinkels; M E Altink; E A Fliers; N N J Rommelse; R B Minderaa; J A Sergeant; S V Faraone; J K Buitelaar
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

7.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

8.  Widespread reductions in cortical thickness following severe early-life deprivation: a neurodevelopmental pathway to attention-deficit/hyperactivity disorder.

Authors:  Katie A McLaughlin; Margaret A Sheridan; Warren Winter; Nathan A Fox; Charles H Zeanah; Charles A Nelson
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

Review 9.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

10.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.